
Compute Power Challenge: The Race To Accelerate Data Movement
Exciting developments in AI inference—like chain-of-thought prompting, which breaks down large, complex questions and prompts into smaller steps mimicking human reasoning—are opening the gates to the highest quality answers and transparency in the logical inference process of AI.
However, this leap in computing puts even more pressure on already-strained computing resources. New AI infrastructure packs more onto each chip, increasing complexity and power. Recent research from Polytechnique Insights estimates that by 2027, AI servers could consume 85 to 134 terawatt-hours of electricity every year.
The challenges of faster and 'smarter' AI are not new, but the level of computing demand has forced a rethinking of chip and server architecture.
Data Movement: A Critical Limiter
Take, for example, OpenAI's comments on the compute horsepower required for its high-quality image generation tools "melting" graphics processing units. The complexity and speed at which AI images were created led to forced temporary rate limits and longer processing times, a prime example of the relentless demand for more compute power in AI systems.
As the demand for faster computation grows, the fast movement of data back and forth between compute engines and memory creates a litany of problems in terms of cooling, power delivery and reliability.
Faster processing demands faster data delivery, or the benefits of better computation are unrealized. The industry is faced with reworking the infrastructure: moving data closer to the memory, creating shortcuts to reduce the distance data travels and preserving energy and power.
A Turning Point For GPU Architecture
At the chip level, the industry is investigating stacking.
The stacked configuration allows more bits and larger capacity in the same footprint, reducing the distance and, in turn, reducing data movement power. As the chips are stacked, wires are added to create the connections between the stacked die and the processor. This creates a much more efficient flow of data.
However, the process of introducing more wires creates a new set of power and thermal management issues as the system does more work in a smaller volume.
Raising The Voltage To Save The Cabling
Another growing pain point for the industry is the amount of electrical current coursing through the cables to power AI systems. Data centers have traditionally used 12-volt power distribution to supply power to servers, and as power consumption dramatically rose, so too did the amount of current.
Copper cables are the industry standard; these wires have a small amount of resistance. When current passes through them, they heat up, and some of the power is lost in 12-volt systems. The required current has grown so high that the heat that would be generated can potentially melt some existing cables.
To reduce the current, industry leaders are switching power distribution infrastructure to 48 volts. On a static basis, this cuts current levels by a factor of four for the same power. But given the projected growth in AI, power demands will continue their heady rise, and the industry is beginning to discuss infrastructure at much higher voltages, including 400 volts and higher.
One challenge is that the GPUs and other chips for AI use very low voltages, on the order of 1 volt or less. A conversion is required to step down the power from 12, 48 or higher voltage needed by chips. Each voltage conversion comes with some energy loss, so the goal is to accomplish this step-down in as few conversions as possible. Further, the conversion should be done as close as possible to the chips to minimize the distance, which in turn reduces power losses and heat generated when moving the stepped-down power to the components that need it.
Power management integrated circuits (PMICs) will be an increasingly critical part of the compute power distribution infrastructure in the future. These chips convert from the higher voltages used to move power within a data center to the low voltages required by the GPUs and other computing chips. PMICs can be placed near the chips they serve, keeping the distance the current travels to a minimum.
The Heat Is On: Liquid Cooling To The Rescue
Heat is an inevitable byproduct when chips are at work. As chips heat up, expansion occurs, leading to mechanical challenges, including cracking and stress-induced failures from thermal cycling. And perhaps most importantly, the risk of data loss increases as chips become overheated. Temperature sensors can mitigate these issues by alerting host processors when heat flares. Even so, sometimes these systems are not enough.
Traditional cooling systems, which use forced air blowing over heatsinks, are not designed to handle the power densities of AI servers. And with cooling and ventilation systems accounting for 30% to 55% of data center power consumption, efficiency is becoming more critical.
In the past, systems used chilled air to help with thermal regulation, but with rising power consumption and increased compute density, this solution is no longer sufficient. More recently, the industry has turned to liquid cooling. Compared to previous solutions, liquid cooling offers a much higher capacity to transfer heat compared to air, making it a good solution for current and future AI systems.
But there are tradeoffs: Modern liquid cooling systems can cost between $1,000 to $2,000 per kW cooled. Liquid cooling machinery is also much heavier than traditional systems, requiring data centers to install infrastructure, including pumps and, in some cases, stronger flooring to support the weight of the machinery and liquid.
As more data centers for AI servers are built, we'll likely see a move to this form of thermal management, even if the upfront cost is higher.
Powering The Future
The demand for better AI shows no signs of slowing down. As new capabilities arise, AI will unleash new value creation. The computing hardware for AI workloads will continue to require increasing amounts of power that will generate more heat.
Key technologies in the semiconductor industry, including chip packaging, power distribution and thermal management, will only grow in importance and drive new innovations to keep pace.
Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify?

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 minutes ago
- Yahoo
Faraday Future Kicks Off Trial Production Phase of its FX Super One MPV at its Hanford, CA Manufacturing Facility, Advancing Engineering and Safety Testing
HANFORD, Calif., August 01, 2025--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) ("Faraday Future", "FF" or the "Company"), a California-based global shared intelligent electric mobility ecosystem company, today announced that its newly-unveiled First Class EAI-MPV model, the FX Super One, has commenced its trial production phase at its Hanford, CA factory. The trial production phase is primarily focused on planning and verifying production processes, operational workflows, and quality standards. In parallel, engineers and production staff at the Hanford factory are undergoing specialized training to support production readiness. Following this phase, the Company will proceed with comprehensive vehicle engineering of the vehicle, which includes extensive safety testing and validation. These efforts are integral to ensuring that the FX Super One meets the highest standards of quality, performance, safety, and the end user experience. The FX Super One was unveiled on July 17 in Los Angeles and showcased the Super EAI F.A.C.E. (Front AI Communication Ecosystem) and the FF EAI Embodied AI Agent 6x4 Architecture. The vehicle is positioned as an EAI-MPV that aims to redefine the traditional mobility experience long dominated by models such as the Cadillac Escalade. Faraday Future's current 1.1 million-square-foot manufacturing and production facility in Hanford, California, named "FF ieFactory California," has approximately $300 million invested so far in the multi-use facility, and with additional investment and permitting, could become capable of producing more than 30,000 vehicles annually. The Company's Hanford factory could prepare a flexible production line for FX units, including FF. The facility would support mixed-line manufacturing or assembly for multiple models. The Company recently completed a new round of financing commitment totaling $105 million, which is expected to nearly cover the launch of the FX Super One. ABOUT FARADAY FUTURE Faraday Future is a California-based global shared intelligent electric mobility ecosystem company. Founded in 2014, the Company's mission is to disrupt the automotive industry by creating a user-centric, technology-first, and smart driving experience. Faraday Future's flagship model, the FF 91, exemplifies its vision for luxury, innovation, and performance. The FX strategy aims to introduce mass production models equipped with state-of-the-art luxury technology similar to the FF 91, targeting a broader market with middle-to-low price range offerings. FF is committed to redefining mobility through AI innovation. Join us in shaping the future of intelligent transportation. For more information, please visit FORWARD LOOKING STATEMENTS This press release includes "forward looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words "could," "will," "should," and "future," variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements, which include statements regarding production capacity expansion, the FX brand, the Super One MPV, future FX models, future FX reservations, expansion into new states and markets, and production and sales goals, are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. View source version on Contacts Investors (English): ir@ Investors (Chinese): cn-ir@ Media: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Business Wire
5 minutes ago
- Business Wire
Faraday Future Kicks Off Trial Production Phase of its FX Super One MPV at its Hanford, CA Manufacturing Facility, Advancing Engineering and Safety Testing
HANFORD, Calif.--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) ('Faraday Future', 'FF' or the 'Company'), a California-based global shared intelligent electric mobility ecosystem company, today announced that its newly-unveiled First Class EAI-MPV model, the FX Super One, has commenced its trial production phase at its Hanford, CA factory. The trial production phase is primarily focused on planning and verifying production processes, operational workflows, and quality standards. In parallel, engineers and production staff at the Hanford factory are undergoing specialized training to support production readiness. Following this phase, the Company will proceed with comprehensive vehicle engineering of the vehicle, which includes extensive safety testing and validation. These efforts are integral to ensuring that the FX Super One meets the highest standards of quality, performance, safety, and the end user experience. The FX Super One was unveiled on July 17 in Los Angeles and showcased the Super EAI F.A.C.E. (Front AI Communication Ecosystem) and the FF EAI Embodied AI Agent 6x4 Architecture. The vehicle is positioned as an EAI-MPV that aims to redefine the traditional mobility experience long dominated by models such as the Cadillac Escalade. Faraday Future's current 1.1 million-square-foot manufacturing and production facility in Hanford, California, named 'FF ieFactory California,' has approximately $300 million invested so far in the multi-use facility, and with additional investment and permitting, could become capable of producing more than 30,000 vehicles annually. The Company's Hanford factory could prepare a flexible production line for FX units, including FF. The facility would support mixed-line manufacturing or assembly for multiple models. The Company recently completed a new round of financing commitment totaling $105 million, which is expected to nearly cover the launch of the FX Super One. ABOUT FARADAY FUTURE Faraday Future is a California-based global shared intelligent electric mobility ecosystem company. Founded in 2014, the Company's mission is to disrupt the automotive industry by creating a user-centric, technology-first, and smart driving experience. Faraday Future's flagship model, the FF 91, exemplifies its vision for luxury, innovation, and performance. The FX strategy aims to introduce mass production models equipped with state-of-the-art luxury technology similar to the FF 91, targeting a broader market with middle-to-low price range offerings. FF is committed to redefining mobility through AI innovation. Join us in shaping the future of intelligent transportation. For more information, please visit FORWARD LOOKING STATEMENTS This press release includes 'forward looking statements' within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words 'could,' 'will,' 'should,' and 'future,' variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements, which include statements regarding production capacity expansion, the FX brand, the Super One MPV, future FX models, future FX reservations, expansion into new states and markets, and production and sales goals, are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements.


Medscape
5 minutes ago
- Medscape
Unnecessary Blood Culture Testing Persists in Pediatrics
Rates of routine blood culture (BC) testing for uncomplicated infections in children had no significant effect on length of stay, costs, return emergency department visits, or hospital readmissions, according to data from nearly 95,000 hospitalizations presented at the Pediatric Hospital Medicine (PHM) 2025. Routine BC testing has shown minimal value in the clinical management of uncomplicated community-acquired pneumonia (CAP), skin and soft tissue infections (SSTI), and urinary tract infections (UTI), according to Smit K. Shah, MD, a clinical assistant professor of pediatrics at the University of Missouri-Kansas City School of Medicine, who presented the findings at the meeting. While such BC testing in an otherwise healthy pediatric population has low clinical benefit, said Shah in an interview, 'downstream harms of such testing may be leading to not just healthcare waste but patient harm.' To review the effect of BC testing patterns on outcomes, Shah and colleagues identified hospitalizations for patients aged 3 months to 18 years admitted with CAP, SSTI, or UTI from 2016 to 2023. The data on 94,524 hospitalizations across 31 hospitals came from the Pediatric Health Information System database. The researchers excluded patients with complicated infections, ICU admission, or hospital stays longer than 1 week. Hospitals were characterized as low-, moderate-, or high-BC testers (13, 10, and 8 hospitals, respectively). The primary outcomes were rates of blood culture testing by infection and hospital, annual rates of testing over 8 years, and clinical outcomes including length of hospital stay, costs, emergency department return visits, and hospital readmissions. The researchers reviewed data for 41% of CAP, 45% of SSTI, and 55% of UTI cases. BC testing rates varied widely; the widest range was from 16% to 77% for low-testing and high-testing hospitals for CAP, respectively. BC testing ranged from approximately 38% to 77% for SSTI and from approximately 22% to 77% for UTI for the low-testing and high-testing hospitals. Over the study period, seven hospitals showed significant increases, 17 showed no changes, and seven showed decreases in annual BC testing. Overall, no significant differences appeared between the high- and low-testing groups in outcome measures of adjusted length of stay, costs, emergency department return visits, hospital readmissions at 7 days, or bacteremia. The findings were limited by several factors including the use of administrative data and potential lack of generalizability to nonacademic hospitals, Shah noted. Many hospitals showed no reduction in BC testing over time, despite growing evidence of no change in outcomes, Shah said in his presentation. The results of the current study suggest that the reassessment of BC use and reduction of unnecessary testing is needed to optimize resources and improve healthcare value, Shah concluded. What Drives Disregard for Guidelines Despite guidelines from the American Academy of Pediatrics on the futility of BC testing in uncomplicated SSTIs, the proportion of hospitalized children with this infection undergoing testing is alarming and continues to remain high over time, Shah told Medscape Medical News . 'We need to understand drivers of unnecessary testing,' said Shah. Identifying whether unnecessary testing stems from institutional factors or lack of education about futility and downstream effects of unnecessary testing would help direct national stewardship efforts to reduce testing overuse, he said. 'The recent blood culture vial shortage could act as a natural experiment in reducing testing,' Shah noted 'Diagnostic stewardship in regard to blood cultures is important as overuse of blood cultures when not clinically indicated has the potential to lead to false-positive results, antibiotic overuse, antibiotic resistance, and can potentially increase healthcare costs,' said Shirin Mazumder, MD, an infectious diseases specialist in Memphis, Tennessee, in an interview. 'Evaluating scenarios where blood cultures may not be clinically indicated can help to address these issues,' said Mazumder, who was not involved in the study. The fear of missing an invasive infection and changing long-standing practice habits are some barriers to reducing unnecessary BC culture testing, but they can be overcome in part by sharing available study data, said Mazumder. In addition, the development of guidelines to determine which candidates would or would not benefit from BCs would help guide clinicians in best practices, she said. This study was supported in part by grants from the Agency for Healthcare Research and Quality to two of the coauthors. Shah reported no financial conflicts of interest.